Taufiek Konrad Rajab
Concepts (468)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 34 | 2024 | 316 | 17.270 |
Why?
| Tissue Adhesions | 25 | 2021 | 32 | 6.070 |
Why?
| Heart Valve Prosthesis Implantation | 10 | 2024 | 101 | 5.730 |
Why?
| Heart Valve Prosthesis | 10 | 2024 | 97 | 5.720 |
Why?
| Lung Transplantation | 10 | 2022 | 38 | 4.680 |
Why?
| Tissue Donors | 11 | 2024 | 123 | 3.530 |
Why?
| Aortic Valve | 14 | 2024 | 126 | 3.500 |
Why?
| Heart Valves | 7 | 2024 | 22 | 3.400 |
Why?
| Cardiac Surgical Procedures | 9 | 2024 | 337 | 3.080 |
Why?
| Pulmonary Valve | 5 | 2024 | 47 | 3.060 |
Why?
| Tissue and Organ Procurement | 6 | 2021 | 48 | 2.900 |
Why?
| Organ Transplantation | 4 | 2023 | 54 | 2.560 |
Why?
| Bioprosthesis | 4 | 2023 | 35 | 2.550 |
Why?
| Postoperative Complications | 13 | 2022 | 1067 | 2.460 |
Why?
| Heart Defects, Congenital | 9 | 2024 | 621 | 2.310 |
Why?
| Heart Valve Diseases | 5 | 2024 | 50 | 2.200 |
Why?
| Bioartificial Organs | 3 | 2020 | 3 | 2.190 |
Why?
| Humans | 107 | 2024 | 54488 | 2.160 |
Why?
| Lung | 7 | 2022 | 523 | 2.040 |
Why?
| Thrombosis | 3 | 2023 | 257 | 1.970 |
Why?
| Peritoneal Diseases | 8 | 2013 | 15 | 1.910 |
Why?
| Extracorporeal Membrane Oxygenation | 4 | 2023 | 308 | 1.880 |
Why?
| Peritoneum | 8 | 2017 | 20 | 1.850 |
Why?
| Truncus Arteriosus, Persistent | 2 | 2024 | 7 | 1.840 |
Why?
| Models, Animal | 7 | 2024 | 268 | 1.840 |
Why?
| Transplantation, Heterologous | 5 | 2024 | 78 | 1.800 |
Why?
| Transplants | 2 | 2023 | 20 | 1.780 |
Why?
| Tissue Scaffolds | 5 | 2020 | 38 | 1.760 |
Why?
| Biocompatible Materials | 7 | 2019 | 74 | 1.730 |
Why?
| Graft Rejection | 8 | 2024 | 164 | 1.690 |
Why?
| Tissue Engineering | 4 | 2020 | 67 | 1.680 |
Why?
| Organ Preservation | 2 | 2022 | 25 | 1.570 |
Why?
| Animals | 42 | 2024 | 14786 | 1.530 |
Why?
| Child | 19 | 2024 | 7480 | 1.510 |
Why?
| Aortic Valve Stenosis | 3 | 2021 | 77 | 1.500 |
Why?
| Echocardiography | 7 | 2024 | 389 | 1.500 |
Why?
| Norwood Procedures | 2 | 2021 | 59 | 1.470 |
Why?
| Heart Neoplasms | 3 | 2019 | 35 | 1.440 |
Why?
| Hypoplastic Left Heart Syndrome | 2 | 2021 | 101 | 1.410 |
Why?
| Heart Failure | 7 | 2022 | 486 | 1.380 |
Why?
| Thoracic Surgery | 3 | 2017 | 16 | 1.330 |
Why?
| Suture Techniques | 4 | 2014 | 71 | 1.310 |
Why?
| Heart-Assist Devices | 4 | 2024 | 151 | 1.260 |
Why?
| Ischemia | 3 | 2014 | 183 | 1.220 |
Why?
| Aortic Valve Insufficiency | 3 | 2022 | 24 | 1.200 |
Why?
| Perfusion | 4 | 2022 | 51 | 1.160 |
Why?
| Swine | 9 | 2024 | 446 | 1.140 |
Why?
| Tourniquets | 2 | 2023 | 9 | 1.110 |
Why?
| Rats | 19 | 2024 | 3666 | 1.110 |
Why?
| Forecasting | 3 | 2024 | 164 | 1.090 |
Why?
| Rodentia | 2 | 2024 | 22 | 1.050 |
Why?
| Disease Models, Animal | 11 | 2024 | 1652 | 1.030 |
Why?
| Infant, Newborn | 11 | 2024 | 2933 | 1.020 |
Why?
| Transplantation, Homologous | 5 | 2023 | 154 | 1.020 |
Why?
| Death | 3 | 2020 | 24 | 1.010 |
Why?
| Vitrification | 1 | 2024 | 4 | 0.970 |
Why?
| Adult | 28 | 2024 | 14232 | 0.970 |
Why?
| Cryoprotective Agents | 1 | 2024 | 7 | 0.960 |
Why?
| Shock, Hemorrhagic | 2 | 2014 | 12 | 0.950 |
Why?
| Out-of-Hospital Cardiac Arrest | 2 | 2021 | 27 | 0.950 |
Why?
| Internship and Residency | 5 | 2017 | 506 | 0.950 |
Why?
| Pelvic Bones | 2 | 2014 | 13 | 0.950 |
Why?
| Treatment Outcome | 20 | 2024 | 5588 | 0.940 |
Why?
| Cryopreservation | 1 | 2024 | 33 | 0.940 |
Why?
| Aortic Diseases | 2 | 2022 | 55 | 0.920 |
Why?
| Immunosuppressive Agents | 2 | 2022 | 247 | 0.910 |
Why?
| Hyaluronic Acid | 4 | 2017 | 39 | 0.880 |
Why?
| Fractures, Bone | 2 | 2014 | 120 | 0.870 |
Why?
| Follow-Up Studies | 10 | 2023 | 2355 | 0.860 |
Why?
| Coronary Artery Bypass | 4 | 2019 | 133 | 0.840 |
Why?
| Puerperal Disorders | 3 | 2018 | 23 | 0.800 |
Why?
| Rats, Wistar | 12 | 2017 | 259 | 0.800 |
Why?
| Biological Evolution | 1 | 2021 | 36 | 0.790 |
Why?
| Informed Consent | 2 | 2013 | 99 | 0.780 |
Why?
| Polymers | 1 | 2020 | 45 | 0.760 |
Why?
| Heart Arrest | 1 | 2023 | 161 | 0.750 |
Why?
| Female | 39 | 2024 | 28506 | 0.750 |
Why?
| Airway Extubation | 1 | 2021 | 39 | 0.750 |
Why?
| Coronary Aneurysm | 2 | 2010 | 22 | 0.750 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2021 | 138 | 0.710 |
Why?
| Eisenmenger Complex | 1 | 2019 | 2 | 0.710 |
Why?
| Heart-Lung Transplantation | 1 | 2019 | 2 | 0.710 |
Why?
| Fontan Procedure | 1 | 2020 | 61 | 0.710 |
Why?
| Dextrocardia | 1 | 2019 | 5 | 0.700 |
Why?
| Paraganglioma | 1 | 2019 | 14 | 0.700 |
Why?
| Fellowships and Scholarships | 2 | 2017 | 122 | 0.690 |
Why?
| Tracheal Stenosis | 1 | 2019 | 11 | 0.690 |
Why?
| Heart Septal Defects, Atrial | 1 | 2019 | 47 | 0.680 |
Why?
| Evidence-Based Medicine | 1 | 2020 | 278 | 0.670 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 492 | 0.670 |
Why?
| Soybean Oil | 1 | 2018 | 6 | 0.660 |
Why?
| Trachea | 1 | 2019 | 53 | 0.660 |
Why?
| Digital Rectal Examination | 1 | 2018 | 3 | 0.650 |
Why?
| Proctoscopy | 1 | 2018 | 4 | 0.650 |
Why?
| Phospholipids | 1 | 2018 | 67 | 0.640 |
Why?
| Infant | 7 | 2024 | 3907 | 0.640 |
Why?
| Surgical Procedures, Operative | 2 | 2010 | 82 | 0.640 |
Why?
| Coronary Stenosis | 1 | 2019 | 104 | 0.620 |
Why?
| Abnormalities, Multiple | 1 | 2019 | 166 | 0.620 |
Why?
| Travel | 1 | 2017 | 35 | 0.600 |
Why?
| Reperfusion Injury | 1 | 2018 | 122 | 0.600 |
Why?
| Retrospective Studies | 14 | 2022 | 6513 | 0.580 |
Why?
| Pneumonia, Viral | 1 | 2020 | 179 | 0.580 |
Why?
| Aorta | 3 | 2024 | 177 | 0.570 |
Why?
| Coronavirus Infections | 1 | 2020 | 188 | 0.570 |
Why?
| Abdominal Wall | 3 | 2021 | 13 | 0.570 |
Why?
| Percutaneous Coronary Intervention | 1 | 2020 | 324 | 0.560 |
Why?
| Education, Medical, Graduate | 2 | 2017 | 231 | 0.540 |
Why?
| Oxygen | 1 | 2018 | 360 | 0.530 |
Why?
| General Surgery | 2 | 2016 | 114 | 0.520 |
Why?
| Pandemics | 1 | 2020 | 590 | 0.510 |
Why?
| Cardiovascular Diseases | 1 | 2020 | 488 | 0.510 |
Why?
| Anticoagulants | 3 | 2023 | 277 | 0.490 |
Why?
| Male | 23 | 2024 | 27634 | 0.490 |
Why?
| Laparoscopy | 4 | 2010 | 191 | 0.490 |
Why?
| Surgical Instruments | 2 | 2015 | 37 | 0.480 |
Why?
| Intraoperative Period | 1 | 2014 | 51 | 0.480 |
Why?
| Lasers, Semiconductor | 1 | 2013 | 11 | 0.460 |
Why?
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 5 | 0.450 |
Why?
| Transplantation, Heterotopic | 2 | 2024 | 7 | 0.450 |
Why?
| Hypotension | 1 | 2014 | 67 | 0.450 |
Why?
| Hemodynamics | 4 | 2023 | 253 | 0.450 |
Why?
| Transplantation, Autologous | 3 | 2020 | 476 | 0.440 |
Why?
| Femoral Artery | 1 | 2014 | 119 | 0.440 |
Why?
| Surgery, Computer-Assisted | 1 | 2013 | 59 | 0.430 |
Why?
| Pregnancy, Ectopic | 2 | 2009 | 9 | 0.430 |
Why?
| Polyesters | 2 | 2010 | 7 | 0.430 |
Why?
| Jejunum | 1 | 2012 | 61 | 0.430 |
Why?
| Endoscopy | 1 | 2013 | 135 | 0.420 |
Why?
| Electrocoagulation | 2 | 2009 | 12 | 0.420 |
Why?
| Prednisolone | 1 | 2012 | 64 | 0.420 |
Why?
| Hyperglycemia | 1 | 2012 | 87 | 0.420 |
Why?
| Middle Aged | 13 | 2024 | 13024 | 0.410 |
Why?
| Coronary Vessels | 2 | 2010 | 175 | 0.410 |
Why?
| Abdominal Injuries | 2 | 2012 | 39 | 0.410 |
Why?
| Biomedical Engineering | 3 | 2020 | 4 | 0.410 |
Why?
| Receptors, Tachykinin | 1 | 2011 | 2 | 0.410 |
Why?
| Pericardiectomy | 1 | 2011 | 6 | 0.410 |
Why?
| Pericarditis, Constrictive | 1 | 2011 | 3 | 0.410 |
Why?
| Enteral Nutrition | 1 | 2012 | 155 | 0.400 |
Why?
| Hernia, Umbilical | 1 | 2011 | 19 | 0.400 |
Why?
| Syphilis, Cardiovascular | 1 | 2011 | 2 | 0.400 |
Why?
| Tomography, X-Ray Computed | 5 | 2020 | 1240 | 0.390 |
Why?
| Glucose | 3 | 2012 | 378 | 0.390 |
Why?
| Myxoma | 1 | 2011 | 18 | 0.390 |
Why?
| Adolescent | 6 | 2024 | 6939 | 0.390 |
Why?
| Angina Pectoris | 1 | 2010 | 19 | 0.380 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2011 | 29 | 0.380 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 177 | 0.380 |
Why?
| Kidney Transplantation | 1 | 2013 | 197 | 0.380 |
Why?
| Microsurgery | 1 | 2010 | 35 | 0.370 |
Why?
| Anastomosis, Surgical | 1 | 2010 | 73 | 0.370 |
Why?
| Aorta, Abdominal | 1 | 2010 | 45 | 0.370 |
Why?
| Vena Cava, Inferior | 1 | 2010 | 82 | 0.360 |
Why?
| Glucans | 2 | 2010 | 10 | 0.360 |
Why?
| Bioengineering | 2 | 2020 | 3 | 0.350 |
Why?
| Incidence | 3 | 2023 | 1090 | 0.350 |
Why?
| Hemangioma | 1 | 2010 | 86 | 0.350 |
Why?
| Consent Forms | 1 | 2009 | 6 | 0.350 |
Why?
| RNA, Messenger | 3 | 2012 | 1230 | 0.340 |
Why?
| Cautery | 1 | 2008 | 3 | 0.340 |
Why?
| Child, Preschool | 3 | 2023 | 4221 | 0.340 |
Why?
| Gels | 1 | 2008 | 20 | 0.340 |
Why?
| Ovary | 1 | 2009 | 105 | 0.330 |
Why?
| Text Messaging | 1 | 2009 | 20 | 0.330 |
Why?
| Sutures | 1 | 2008 | 46 | 0.330 |
Why?
| Tuberculosis, Spinal | 1 | 2008 | 5 | 0.320 |
Why?
| Reoperation | 2 | 2021 | 466 | 0.320 |
Why?
| Blood Pressure | 3 | 2023 | 570 | 0.320 |
Why?
| Vascular Surgical Procedures | 1 | 2010 | 181 | 0.320 |
Why?
| Hydrogels | 1 | 2008 | 12 | 0.320 |
Why?
| Polyglutamic Acid | 1 | 2008 | 1 | 0.320 |
Why?
| Cellulose, Oxidized | 1 | 2008 | 4 | 0.320 |
Why?
| Low Back Pain | 1 | 2008 | 30 | 0.310 |
Why?
| Skin, Artificial | 1 | 2007 | 10 | 0.310 |
Why?
| Ontario | 2 | 2017 | 53 | 0.310 |
Why?
| Physician-Patient Relations | 1 | 2009 | 133 | 0.310 |
Why?
| Uterine Diseases | 1 | 2007 | 11 | 0.310 |
Why?
| Gelatin | 1 | 2007 | 27 | 0.300 |
Why?
| United States | 9 | 2024 | 5286 | 0.300 |
Why?
| Pregnancy | 7 | 2023 | 2579 | 0.300 |
Why?
| Skin Transplantation | 1 | 2007 | 47 | 0.300 |
Why?
| Stents | 3 | 2020 | 367 | 0.300 |
Why?
| Lumbar Vertebrae | 1 | 2008 | 105 | 0.300 |
Why?
| Pericardium | 2 | 2021 | 31 | 0.290 |
Why?
| Heart Arrest, Induced | 2 | 2017 | 7 | 0.290 |
Why?
| Patient Education as Topic | 1 | 2010 | 331 | 0.290 |
Why?
| Patient Satisfaction | 1 | 2009 | 301 | 0.290 |
Why?
| Radiography | 3 | 2013 | 531 | 0.280 |
Why?
| Heart Atria | 2 | 2019 | 60 | 0.270 |
Why?
| Materials Testing | 2 | 2020 | 66 | 0.270 |
Why?
| Young Adult | 5 | 2023 | 4324 | 0.270 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 536 | 0.260 |
Why?
| Burns | 1 | 2007 | 171 | 0.260 |
Why?
| Attitude of Health Personnel | 1 | 2009 | 389 | 0.260 |
Why?
| Physicians | 1 | 2009 | 248 | 0.260 |
Why?
| Aged | 8 | 2023 | 10030 | 0.250 |
Why?
| Papio | 1 | 2024 | 16 | 0.250 |
Why?
| Thermography | 2 | 2017 | 13 | 0.250 |
Why?
| Graft Survival | 2 | 2022 | 166 | 0.250 |
Why?
| Tissue Banks | 1 | 2024 | 9 | 0.240 |
Why?
| Myocardium | 3 | 2011 | 450 | 0.240 |
Why?
| Coronary Angiography | 2 | 2019 | 367 | 0.230 |
Why?
| Membranes, Artificial | 3 | 2017 | 17 | 0.230 |
Why?
| Primates | 1 | 2023 | 23 | 0.230 |
Why?
| Regeneration | 2 | 2021 | 77 | 0.230 |
Why?
| Blood Coagulation | 1 | 2023 | 66 | 0.220 |
Why?
| Thigh | 1 | 2023 | 41 | 0.220 |
Why?
| Rats, Sprague-Dawley | 3 | 2018 | 1784 | 0.220 |
Why?
| Mycophenolic Acid | 1 | 2022 | 19 | 0.220 |
Why?
| Peritoneal Cavity | 2 | 2013 | 8 | 0.220 |
Why?
| Prosthesis Design | 2 | 2020 | 256 | 0.210 |
Why?
| Transposition of Great Vessels | 1 | 2022 | 26 | 0.210 |
Why?
| Lower Extremity | 1 | 2023 | 105 | 0.210 |
Why?
| Tacrolimus | 1 | 2022 | 55 | 0.210 |
Why?
| Rats, Inbred Lew | 2 | 2019 | 73 | 0.210 |
Why?
| Vascular Diseases | 1 | 2022 | 77 | 0.210 |
Why?
| Blood Group Incompatibility | 1 | 2021 | 6 | 0.210 |
Why?
| Pentalogy of Cantrell | 1 | 2021 | 1 | 0.210 |
Why?
| Polytetrafluoroethylene | 1 | 2021 | 38 | 0.200 |
Why?
| Referral and Consultation | 1 | 2024 | 304 | 0.200 |
Why?
| Thorax | 1 | 2021 | 16 | 0.200 |
Why?
| Electric Impedance | 1 | 2021 | 45 | 0.200 |
Why?
| Diverticulum | 1 | 2021 | 23 | 0.200 |
Why?
| Propensity Score | 2 | 2019 | 139 | 0.200 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2021 | 42 | 0.200 |
Why?
| Infant, Premature, Diseases | 1 | 2022 | 95 | 0.200 |
Why?
| Metastasectomy | 1 | 2021 | 2 | 0.200 |
Why?
| Mitral Valve | 1 | 2021 | 68 | 0.190 |
Why?
| Abdomen | 2 | 2012 | 86 | 0.190 |
Why?
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 58 | 0.190 |
Why?
| Dyspnea | 2 | 2011 | 79 | 0.190 |
Why?
| Digestive System Surgical Procedures | 2 | 2012 | 38 | 0.190 |
Why?
| Brain Death | 1 | 2020 | 16 | 0.180 |
Why?
| Premature Birth | 1 | 2022 | 151 | 0.180 |
Why?
| Graft vs Host Disease | 1 | 2020 | 77 | 0.180 |
Why?
| History, 21st Century | 1 | 2020 | 65 | 0.180 |
Why?
| Infant, Newborn, Diseases | 1 | 2020 | 66 | 0.180 |
Why?
| Postoperative Period | 1 | 2020 | 186 | 0.180 |
Why?
| Pulsatile Flow | 1 | 2019 | 19 | 0.180 |
Why?
| Sarcoma | 1 | 2021 | 73 | 0.180 |
Why?
| Ankle Injuries | 1 | 2019 | 15 | 0.180 |
Why?
| History, 20th Century | 1 | 2020 | 121 | 0.180 |
Why?
| Equipment Design | 1 | 2020 | 313 | 0.180 |
Why?
| Heart | 2 | 2020 | 350 | 0.180 |
Why?
| Ventricular Fibrillation | 1 | 2019 | 18 | 0.170 |
Why?
| Islets of Langerhans | 1 | 2019 | 24 | 0.170 |
Why?
| Radiography, Thoracic | 1 | 2019 | 70 | 0.170 |
Why?
| Interdisciplinary Communication | 1 | 2019 | 65 | 0.170 |
Why?
| Survival Analysis | 1 | 2021 | 711 | 0.170 |
Why?
| Fat Emulsions, Intravenous | 1 | 2018 | 12 | 0.170 |
Why?
| Temperature | 1 | 2019 | 180 | 0.170 |
Why?
| Emulsions | 1 | 2018 | 30 | 0.160 |
Why?
| Health Services Needs and Demand | 1 | 2020 | 188 | 0.160 |
Why?
| Proctoscopes | 1 | 2018 | 1 | 0.160 |
Why?
| Palliative Care | 1 | 2020 | 189 | 0.160 |
Why?
| Anal Canal | 1 | 2018 | 26 | 0.160 |
Why?
| Heart, Artificial | 1 | 2018 | 3 | 0.160 |
Why?
| Colistin | 1 | 2018 | 7 | 0.160 |
Why?
| Polysaccharides | 1 | 2018 | 57 | 0.160 |
Why?
| Marfan Syndrome | 1 | 2018 | 24 | 0.160 |
Why?
| Comorbidity | 1 | 2020 | 680 | 0.160 |
Why?
| Pneumonia, Bacterial | 1 | 2018 | 27 | 0.160 |
Why?
| Infrared Rays | 1 | 2017 | 27 | 0.160 |
Why?
| Operative Time | 2 | 2015 | 83 | 0.160 |
Why?
| Pseudomonas Infections | 1 | 2018 | 54 | 0.160 |
Why?
| Cecum | 2 | 2008 | 69 | 0.150 |
Why?
| Extracellular Matrix | 1 | 2018 | 118 | 0.150 |
Why?
| Prospective Studies | 2 | 2023 | 2534 | 0.150 |
Why?
| Prosthesis Implantation | 1 | 2018 | 48 | 0.150 |
Why?
| Pseudomonas aeruginosa | 1 | 2018 | 86 | 0.150 |
Why?
| Heparin | 1 | 2018 | 102 | 0.150 |
Why?
| Stem Cells | 1 | 2019 | 193 | 0.150 |
Why?
| Colorectal Neoplasms | 1 | 2021 | 245 | 0.150 |
Why?
| Monitoring, Intraoperative | 1 | 2017 | 65 | 0.150 |
Why?
| Optical Imaging | 1 | 2017 | 29 | 0.150 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2017 | 38 | 0.150 |
Why?
| Cell Proliferation | 1 | 2021 | 1074 | 0.150 |
Why?
| Combined Modality Therapy | 1 | 2019 | 687 | 0.150 |
Why?
| Endocarditis, Non-Infective | 1 | 2016 | 2 | 0.150 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 46 | 0.150 |
Why?
| Age Factors | 1 | 2020 | 1198 | 0.140 |
Why?
| Aged, 80 and over | 3 | 2020 | 3417 | 0.140 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 203 | 0.140 |
Why?
| Thoracoplasty | 1 | 2016 | 3 | 0.140 |
Why?
| Funnel Chest | 1 | 2016 | 10 | 0.140 |
Why?
| Ligation | 2 | 2013 | 66 | 0.140 |
Why?
| Potassium Compounds | 1 | 2015 | 3 | 0.130 |
Why?
| Prosthesis-Related Infections | 1 | 2017 | 109 | 0.130 |
Why?
| Antigens, CD | 1 | 2016 | 236 | 0.130 |
Why?
| Epithelium | 2 | 2012 | 71 | 0.130 |
Why?
| Lung Diseases | 1 | 2016 | 97 | 0.130 |
Why?
| Lidocaine | 1 | 2015 | 51 | 0.130 |
Why?
| Wounds and Injuries | 2 | 2008 | 320 | 0.130 |
Why?
| Lung Neoplasms | 1 | 2021 | 642 | 0.120 |
Why?
| Myocardial Contraction | 2 | 2011 | 113 | 0.120 |
Why?
| Curriculum | 1 | 2017 | 442 | 0.120 |
Why?
| Risk Assessment | 1 | 2019 | 1360 | 0.120 |
Why?
| Free Tissue Flaps | 1 | 2015 | 63 | 0.120 |
Why?
| Germany | 2 | 2010 | 27 | 0.120 |
Why?
| Survival Rate | 3 | 2021 | 938 | 0.120 |
Why?
| Risk Factors | 2 | 2020 | 3917 | 0.120 |
Why?
| Bandages | 1 | 2013 | 23 | 0.120 |
Why?
| Macrophages | 1 | 2016 | 408 | 0.120 |
Why?
| Esophagectomy | 1 | 2014 | 35 | 0.120 |
Why?
| Cell Adhesion | 2 | 2016 | 175 | 0.120 |
Why?
| Laparotomy | 1 | 2013 | 38 | 0.110 |
Why?
| Clinical Competence | 1 | 2016 | 446 | 0.110 |
Why?
| Gastric Bypass | 1 | 2012 | 23 | 0.110 |
Why?
| Esophageal Neoplasms | 1 | 2014 | 102 | 0.110 |
Why?
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2012 | 1 | 0.110 |
Why?
| Histocytochemistry | 1 | 2012 | 47 | 0.110 |
Why?
| Injections, Intraperitoneal | 1 | 2012 | 62 | 0.110 |
Why?
| Heart Diseases | 1 | 2015 | 231 | 0.110 |
Why?
| Succinate Dehydrogenase | 1 | 2012 | 23 | 0.110 |
Why?
| Intraoperative Care | 1 | 2012 | 58 | 0.110 |
Why?
| Cystadenoma, Serous | 1 | 2012 | 5 | 0.100 |
Why?
| Foreign-Body Reaction | 3 | 2017 | 9 | 0.100 |
Why?
| Pancreatic Ducts | 1 | 2012 | 12 | 0.100 |
Why?
| Preoperative Care | 1 | 2013 | 184 | 0.100 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 62 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 233 | 0.100 |
Why?
| Second-Look Surgery | 1 | 2011 | 4 | 0.100 |
Why?
| Isoproterenol | 1 | 2011 | 59 | 0.100 |
Why?
| Acidosis | 1 | 2011 | 36 | 0.100 |
Why?
| Ascites | 1 | 2011 | 27 | 0.100 |
Why?
| Random Allocation | 1 | 2012 | 317 | 0.100 |
Why?
| Pilot Projects | 2 | 2011 | 780 | 0.100 |
Why?
| Biological Science Disciplines | 1 | 2011 | 2 | 0.100 |
Why?
| Endocardium | 1 | 2011 | 5 | 0.100 |
Why?
| Lasers, Excimer | 1 | 2011 | 3 | 0.100 |
Why?
| Diagnosis, Differential | 3 | 2012 | 1155 | 0.100 |
Why?
| Phrenic Nerve | 1 | 2011 | 6 | 0.100 |
Why?
| Cardiotonic Agents | 1 | 2011 | 77 | 0.100 |
Why?
| Mammary Arteries | 1 | 2010 | 10 | 0.100 |
Why?
| Heart Injuries | 1 | 2011 | 17 | 0.100 |
Why?
| AMP-Activated Protein Kinases | 1 | 2010 | 31 | 0.100 |
Why?
| Alopecia | 1 | 2011 | 41 | 0.090 |
Why?
| Infertility | 1 | 2010 | 21 | 0.090 |
Why?
| Scoliosis | 1 | 2011 | 58 | 0.090 |
Why?
| Tinnitus | 1 | 2011 | 65 | 0.090 |
Why?
| Laser Therapy | 1 | 2011 | 91 | 0.090 |
Why?
| Fibrosis | 3 | 2017 | 213 | 0.090 |
Why?
| Disclosure | 1 | 2010 | 43 | 0.090 |
Why?
| Leiomyoma | 1 | 2010 | 31 | 0.090 |
Why?
| Intestinal Obstruction | 1 | 2010 | 39 | 0.090 |
Why?
| Fallopian Tubes | 1 | 2009 | 27 | 0.090 |
Why?
| Electrosurgery | 1 | 2009 | 12 | 0.090 |
Why?
| Wounds, Nonpenetrating | 1 | 2011 | 91 | 0.090 |
Why?
| Uterine Neoplasms | 1 | 2010 | 67 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2010 | 312 | 0.090 |
Why?
| Adenocarcinoma | 1 | 2014 | 425 | 0.090 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2010 | 224 | 0.090 |
Why?
| Cardiomyopathies | 1 | 2010 | 114 | 0.090 |
Why?
| Myocardial Ischemia | 1 | 2010 | 126 | 0.090 |
Why?
| Triplets | 1 | 2009 | 1 | 0.090 |
Why?
| Vagina | 1 | 2009 | 50 | 0.080 |
Why?
| Serous Membrane | 1 | 2008 | 3 | 0.080 |
Why?
| Confidentiality | 1 | 2009 | 39 | 0.080 |
Why?
| Abortion, Therapeutic | 1 | 2008 | 3 | 0.080 |
Why?
| Pancreatic Neoplasms | 1 | 2012 | 235 | 0.080 |
Why?
| Efficiency, Organizational | 1 | 2009 | 50 | 0.080 |
Why?
| Recurrence | 1 | 2010 | 690 | 0.080 |
Why?
| Hot Temperature | 1 | 2009 | 235 | 0.080 |
Why?
| Toxicity Tests | 1 | 2008 | 55 | 0.080 |
Why?
| Spinal Cord Compression | 1 | 2008 | 10 | 0.080 |
Why?
| Electrocardiography | 1 | 2010 | 281 | 0.080 |
Why?
| Takayasu Arteritis | 1 | 2008 | 3 | 0.080 |
Why?
| Autopsy | 1 | 2008 | 52 | 0.080 |
Why?
| Cervix Uteri | 1 | 2008 | 48 | 0.080 |
Why?
| Atrial Fibrillation | 1 | 2011 | 194 | 0.080 |
Why?
| Gynecologic Surgical Procedures | 1 | 2008 | 31 | 0.080 |
Why?
| Cardiac Catheterization | 1 | 2010 | 241 | 0.080 |
Why?
| Veins | 1 | 2008 | 75 | 0.080 |
Why?
| Evaluation Studies as Topic | 1 | 2008 | 109 | 0.080 |
Why?
| Delivery, Obstetric | 1 | 2009 | 107 | 0.080 |
Why?
| Arteries | 1 | 2008 | 102 | 0.080 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2008 | 27 | 0.080 |
Why?
| Internet | 1 | 2010 | 277 | 0.080 |
Why?
| Time Factors | 4 | 2019 | 3220 | 0.080 |
Why?
| Costs and Cost Analysis | 1 | 2007 | 110 | 0.070 |
Why?
| Rabbits | 1 | 2008 | 425 | 0.070 |
Why?
| Attitude to Health | 1 | 2009 | 223 | 0.070 |
Why?
| Ultrasonography | 1 | 2009 | 476 | 0.070 |
Why?
| Uterus | 1 | 2007 | 99 | 0.070 |
Why?
| Sheep | 3 | 2011 | 94 | 0.070 |
Why?
| Heart Ventricles | 2 | 2024 | 260 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2010 | 307 | 0.070 |
Why?
| Cells, Cultured | 1 | 2008 | 1733 | 0.060 |
Why?
| Intra-Aortic Balloon Pumping | 1 | 2024 | 6 | 0.060 |
Why?
| Shock, Cardiogenic | 1 | 2024 | 29 | 0.060 |
Why?
| Severity of Illness Index | 2 | 2018 | 1059 | 0.060 |
Why?
| Prevalence | 2 | 2020 | 1044 | 0.060 |
Why?
| Leg | 1 | 2022 | 132 | 0.050 |
Why?
| Inflammation | 2 | 2017 | 679 | 0.050 |
Why?
| ABO Blood-Group System | 1 | 2021 | 15 | 0.050 |
Why?
| Infant, Low Birth Weight | 1 | 2022 | 77 | 0.050 |
Why?
| Waiting Lists | 1 | 2021 | 49 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 123 | 0.050 |
Why?
| Colorado | 1 | 2020 | 21 | 0.050 |
Why?
| Heart Rate | 1 | 2022 | 348 | 0.050 |
Why?
| Magnetic Resonance Imaging | 1 | 2008 | 1610 | 0.050 |
Why?
| Gestational Age | 1 | 2022 | 408 | 0.050 |
Why?
| Health Policy | 1 | 2021 | 173 | 0.050 |
Why?
| Casts, Surgical | 1 | 2019 | 9 | 0.040 |
Why?
| Splints | 1 | 2019 | 8 | 0.040 |
Why?
| Anesthesia, Local | 1 | 2019 | 19 | 0.040 |
Why?
| Endocrine System | 1 | 2019 | 17 | 0.040 |
Why?
| Click Chemistry | 1 | 2018 | 2 | 0.040 |
Why?
| Azides | 1 | 2018 | 9 | 0.040 |
Why?
| Cardioplegic Solutions | 1 | 2017 | 3 | 0.040 |
Why?
| Computer Systems | 1 | 2017 | 22 | 0.040 |
Why?
| Staining and Labeling | 1 | 2018 | 108 | 0.040 |
Why?
| Chronic Disease | 2 | 2010 | 625 | 0.040 |
Why?
| Enterococcus | 1 | 2017 | 13 | 0.040 |
Why?
| Antiphospholipid Syndrome | 1 | 2016 | 10 | 0.040 |
Why?
| Pneumonectomy | 1 | 2016 | 29 | 0.030 |
Why?
| Epithelial Cells | 1 | 2018 | 260 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 197 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2016 | 79 | 0.030 |
Why?
| Specialties, Surgical | 1 | 2016 | 39 | 0.030 |
Why?
| Endothelial Cells | 1 | 2018 | 293 | 0.030 |
Why?
| Creatine Kinase, MB Form | 1 | 2015 | 6 | 0.030 |
Why?
| Angiography | 1 | 2016 | 140 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 147 | 0.030 |
Why?
| Wound Healing | 1 | 2016 | 224 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2016 | 984 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2015 | 641 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 2014 | 0.030 |
Why?
| Microscopy, Electron, Scanning | 1 | 2012 | 52 | 0.030 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2012 | 9 | 0.030 |
Why?
| Pancreaticoduodenectomy | 1 | 2012 | 13 | 0.030 |
Why?
| Sheep, Domestic | 1 | 2011 | 13 | 0.030 |
Why?
| Logistic Models | 1 | 2015 | 990 | 0.030 |
Why?
| Length of Stay | 1 | 2015 | 685 | 0.030 |
Why?
| Databases, Factual | 1 | 2015 | 697 | 0.030 |
Why?
| Cohort Studies | 1 | 2016 | 1543 | 0.030 |
Why?
| Rupture | 1 | 2011 | 32 | 0.020 |
Why?
| Salaries and Fringe Benefits | 1 | 2010 | 9 | 0.020 |
Why?
| Polystyrenes | 1 | 2010 | 5 | 0.020 |
Why?
| Injections, Intra-Arterial | 1 | 2010 | 14 | 0.020 |
Why?
| Pulmonary Veins | 1 | 2011 | 32 | 0.020 |
Why?
| Microspheres | 1 | 2010 | 33 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 37 | 0.020 |
Why?
| Job Satisfaction | 1 | 2010 | 45 | 0.020 |
Why?
| Certification | 1 | 2010 | 50 | 0.020 |
Why?
| Models, Biological | 1 | 2014 | 808 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 330 | 0.020 |
Why?
| Single-Blind Method | 1 | 2010 | 123 | 0.020 |
Why?
| Stroke Volume | 1 | 2010 | 131 | 0.020 |
Why?
| Mitral Valve Insufficiency | 1 | 2010 | 64 | 0.020 |
Why?
| Hysterectomy | 1 | 2009 | 90 | 0.020 |
Why?
| Ventricular Function, Left | 1 | 2010 | 165 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2011 | 190 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 664 | 0.020 |
Why?
| Blotting, Western | 1 | 2010 | 682 | 0.020 |
Why?
| Phosphorylation | 1 | 2010 | 603 | 0.020 |
Why?
| Pregnancy Tests | 1 | 2008 | 2 | 0.020 |
Why?
| Uterine Hemorrhage | 1 | 2008 | 9 | 0.020 |
Why?
| Chorionic Gonadotropin | 1 | 2008 | 18 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 500 | 0.020 |
Why?
| Sus scrofa | 1 | 2008 | 39 | 0.020 |
Why?
| Treatment Failure | 1 | 2008 | 138 | 0.020 |
Why?
| Sex Factors | 1 | 2010 | 772 | 0.020 |
Why?
| Cesarean Section | 1 | 2009 | 162 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2010 | 1282 | 0.020 |
Why?
| Pregnancy Outcome | 1 | 2008 | 210 | 0.020 |
Why?
| Pregnancy Complications | 1 | 2009 | 377 | 0.020 |
Why?
|
|
Rajab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors ![Expand Description](https://uams-triprofiles.uams.edu/profiles/Framework/Images/info.png) People in Profiles who have published with this person. _
|